TRAIL-enhancing activity of Erythrinan alkaloids from Erythrina velutina

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 1, 2009, Pages 234-236

  Ozawa, Masaaki ^a   Etoh, Tadahiro ^b   Hayashi, Masahiko ^b   Komiyama, Kanki ^c   Kishida, Akio ^a   Ohsaki, Ayumi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b IWAKI MEISEI UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Enhanced activity; Erythrina velutina; Erythrinan alkaloid; Medicinal plant; TRAIL

Indexed keywords

8 OXO ERYTHRALINE; ERYSODINE; ERYSOTRINE; ERYSOVINE; ERYTHRALIN; ERYTHRINA ALKALOID; ERYTHRODINE N OXIDE; GLYCOERYSODINE; HYPAPHORINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; ERYTHRINA; ERYTHRINA VELUTINA; HUMAN; HUMAN CELL; IC 50; PLANT SEED; STRUCTURE ANALYSIS;

ALKALOIDS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; ERYTHRINA; HUMANS; INDOLE ALKALOIDS; JURKAT CELLS; MOLECULAR STRUCTURE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

ERYTHRINA VELUTINA;

EID: 57749085451     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.10.111     Document Type: Article

References (15)

1. Ohsaki A., Takashima J., Chiba N., and Kawamura M. Bioorg. Med. Chem. Lett. 9 (1999) 1109
2. Hashimoto G. Illustrated Cyclopedia of Brazilian Medicinal Plants (1996), ABOC-SHA, Kamakura p 679
3. Dantas M.C., De Oliveira F.S., Bandeira S.M., Batista J.S., Silva C.D., Alves P.B., Antoniolli A.R., and Marchioro M. J. Ethnopharmacol. 94 (2004) 129
4. Ozawa M., Honda K., Nakai I., Kishida A., and Ohsaki A. Bioorg. Med. Chem. Lett. 18 (2008) 3992
5. Takashima J., Ikeda Y., Komiyama K., Hayashi M., Kishida A., and Ohsaki A. Chem. Pharm. Bull. 55 (2007) 343
6. Wang S., and El-Deiry W.S. Oncogene 22 (2003) 8628
7. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., Nakanishi R., Nishino H., and Sakai T. Biochem. Biophys. Res. Commun. 333 (2005) 833
8. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., and Sakai T. Mol. Cancer Ther. 5 (2006) 945 and references therein
9. Chawla A.S., Chunchatprasert S., and Jacson A.H. Org. Magn. Reson. 21 (1983) 39
10. Mantle P.G., Laws I., and Widdowson D.A. Phytochemistry 23 (1984) 1336
11. Amer M.E., and El-Masry S. J. Nat. Prod. 54 (1991) 161
12. Kondo K., Nishi J., and Kobayashi J. J. Nat. Prod. 54 (1994) 161
13. Dagne E., and Steglich W. Tetrahedron Lett. 24 (1983) 5067
14. 3, 125 Hz), δ 125.2 (C-1), 134.2 (C-2), 75.7 (C-3), 31.2 (C-4), 82.9 (C-5), 139.1 (C-6), 117.2 (C-7), 70.9 (C-8), 59.7 (C-10), 27.2 (C-11), 120.0 (C-12), 129.0 (C-13), 112.6 (C-14), 147.6 (C-15), 146.3 (C-16), 110.3 (C-17), 56.0 (C-3-OMe), 55.9 (C-15-OMe).
15. Tsuda Y., and Sano T. The Alkaloids (1996), Academic Press Inc. Vol. 48, p 249